M
Medeloop
An AI-driven platform for conducting early-stage clinical research and trials, simplifying grant applications, data collection, harmonization, biomarker identification, and manuscript submissions
About Medeloop
Medeloop is an AI-driven platform designed to accelerate clinical and public health research. The platform serves researchers, pharmaceutical companies, and healthcare providers by streamlining the entire research process, from generating hypotheses and securing funding to managing studies and analyzing data. Medeloop's business model is centered on providing access to its comprehensive suite of AI tools that automate and enhance various aspects of medical research. The company generates revenue through subscriptions to its platform, which offers features like two-way messaging for patient-care team interaction, advanced data analytics for identifying biomarkers and drug targets, and tools for grant writing and scientific publication. By integrating and harmonizing extensive health data, Medeloop aims to significantly expedite the discovery of new treatments and improve patient outcomes. The company operates in the health-tech market, with a focus on early-stage clinical research and trials.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2021
- Headquarters
- San Francisco, United States
- Employees
- 40
- Open positions
- 3
- Dealroom signal
- 83.7/100
- Industry
- Health
- Sub-industry
- Health Platform
- Sector
- Health Tech & Medtech, Hard Tech
- Technology
- Artificial Intelligence
- Business model
- SaaS
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES A✓Equity / VC | Nov 2024 | $16M | $62M | General Catalyst · Maven Ventures · Inovia Capital · Icon Ventures | ↗ |
| SEED✓Equity / VC | Sep 2023 | $8M | $32M | Maven Ventures · OVO Fund · Kenneth C. Frazier · Linda S. Grais | ↗ |
Growth signals
Latest recorded traffic for Medeloop is 7.5K monthly website visits, up 127.3% over the last three months. Medeloop's team grew 2.6% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed6 investors entered at this stage
General Catalyst
Maven Ventures
OVO Fund- KFKenneth C. Frazier
Linda S. Grais- NINV investments
Series A2 investors entered at this stage
Inovia Capital
Icon Ventures
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Medeloop on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Medeloop’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.